DepoMed (DEPO) Misses Q1 EPS by 14c; Guides FY15 Sales Above Views
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Net income (loss): -12.89M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Net income (loss): -12.89M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
DepoMed (NASDAQ: DEPO) reported Q1 EPS of ($0.13), $0.14 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $31.7 million versus the consensus estimate of $33.8 million.
DepoMed sees FY2015 revenue of $310-335 million, versus the consensus of $305.02 million.
For earnings history and earnings-related data on DepoMed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Park National Corp. (PRK) Tops Q1 EPS by 36c
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
